This paper addresses a few major problems that the pharmaceutical company Pfizer Inc. has recently been facing. The paper also provides promising solutions to these major problems, which without action can lead to the demise of the pharmaceutical giant. The implementation of the proposed solutions would allow Pfizer Inc. to improve its position and inevitably save it from possible demise
The recent AstraZeneca takeover bid from Pfizer puts pharmaceutical R&D once again on the public age...
In recent years, it has become increasingly evident that current tax regulations are not properly e...
Over the next five years, approximately 110 drugs, including blockbuster products such as Sanofi-Ave...
Pfizer was established in 1849 in Brooklyn, New York by cousins Charles Pfizer and Charles Erhart wi...
This case focus on the strategy that motivated Pfizer to go, by 2009, through the acquisition of Wy...
If there is one topic that has drastically affected human society in the last decades, it definitely...
On November 23, 2015, the US drugs giant Pfizer has entered into a definitive merger agreement under...
This project develops an extensive valuation of Pfizer Inc. under the CFA institute’s “Equit...
An innovative pharmaceutical company is known to enjoy a First-Mover Advantage when it launches a pa...
The traditional heavyweights or big pharmas of the modern pharmaceutical industry are facing unprece...
In the research-intensive pharmaceutical industry, two rationales for M&A prevail. First, deals may ...
This paper examines the Pharmaceutical (Pharma) industry and the changes that have occurred particul...
The purpose of this strategic audit report is to provide an in-depth analysis of different aspects o...
This master thesis provides strategic and finical analysis of company Pfizer. The master thesis is d...
Is Pfizer-Wyeth merger aligned with value creation in the pharmaceutical industry? This empirical r...
The recent AstraZeneca takeover bid from Pfizer puts pharmaceutical R&D once again on the public age...
In recent years, it has become increasingly evident that current tax regulations are not properly e...
Over the next five years, approximately 110 drugs, including blockbuster products such as Sanofi-Ave...
Pfizer was established in 1849 in Brooklyn, New York by cousins Charles Pfizer and Charles Erhart wi...
This case focus on the strategy that motivated Pfizer to go, by 2009, through the acquisition of Wy...
If there is one topic that has drastically affected human society in the last decades, it definitely...
On November 23, 2015, the US drugs giant Pfizer has entered into a definitive merger agreement under...
This project develops an extensive valuation of Pfizer Inc. under the CFA institute’s “Equit...
An innovative pharmaceutical company is known to enjoy a First-Mover Advantage when it launches a pa...
The traditional heavyweights or big pharmas of the modern pharmaceutical industry are facing unprece...
In the research-intensive pharmaceutical industry, two rationales for M&A prevail. First, deals may ...
This paper examines the Pharmaceutical (Pharma) industry and the changes that have occurred particul...
The purpose of this strategic audit report is to provide an in-depth analysis of different aspects o...
This master thesis provides strategic and finical analysis of company Pfizer. The master thesis is d...
Is Pfizer-Wyeth merger aligned with value creation in the pharmaceutical industry? This empirical r...
The recent AstraZeneca takeover bid from Pfizer puts pharmaceutical R&D once again on the public age...
In recent years, it has become increasingly evident that current tax regulations are not properly e...
Over the next five years, approximately 110 drugs, including blockbuster products such as Sanofi-Ave...